QNTM
Quantum Biopharma Ltd.
Next earnings Aug 4, 2026
$3.51
▼ -5.14%$3.51▼ -83.38%
over 1Y
L $2.10EODHDH $29.21
Today-5.1%
1W-10.7%
1M-31.3%
3M-11.8%
YTD-49.9%
1Y-83.4%
Sell
Conviction
Horizon
Medium (3–12mo)
Street · 7 analysts
Buy
Mixed signals in the latest filings.
Quantum Biopharma Ltd. shows limited reported revenue.
On these fundamentals, QNTM screens as SELL on the SEC figures.
Financials · annual, by fiscal year
No income data filed.
Annual figures from SEC 10-K XBRL filings. Open the filing links below for full statement detail.
Key statistics
Valuation
Enterprise value$22.5M
EV / EBITDA—
EV / Sales—
EV / FCF—
P / FCF—
PEG (trailing)—
Earnings yield—
FCF yield—
Quality & risk
ROIC (est.)—
Free cash flow—
Total debt—
Net cash—
Capital returns
Buyback yield—
Dividend yield (est.)—
Shareholder yield—
Shares Δ YoY-100.0%
Computed from SEC XBRL annual figures + the current quote. EV and ROIC use long-term + current debt where filed; estimates, not investment advice.
Recent filings
all on EDGAR ↗6-KPeriod ending 2026-06-022026-06-02open ↗6-KPeriod ending 2026-06-022026-06-02open ↗6-KPeriod ending 2026-05-182026-05-18open ↗6-KPeriod ending 2026-05-072026-05-07open ↗6-KPeriod ending 2026-03-312026-05-06open ↗6-KPeriod ending 2026-04-222026-04-22open ↗6-KPeriod ending 2026-04-022026-04-02open ↗6-KPeriod ending 2026-04-012026-04-01open ↗6-KPeriod ending 2026-03-302026-03-30open ↗6-KPeriod ending 2026-03-272026-03-27open ↗20-FPeriod ending 2025-12-312026-03-26open ↗6-KPeriod ending 2026-03-262026-03-26open ↗
Frequently asked
- Is Quantum Biopharma Ltd. (QNTM) a buy?
- QNTM currently carries a Sell rating with 2/5 conviction, derived from its latest SEC filings. Mixed signals in the latest filings.
- What is Quantum Biopharma Ltd.'s quality score?
- QNTM scores 18.505587845314878/100 (grade F) on a SEC-grounded quality model spanning value, growth, profitability, financial health and momentum.
Sources: SEC EDGAR (CIK 0001771885, latest 6-K filed 2026-06-02) · EODHD · as of 7/3/2026, 8:55:09 PM.
Research and education only — not financial advice. EDGAR is not a registered investment adviser or broker-dealer and gives no personalized advice. Every call is impersonal — identical for all users, generated on a schedule from SEC filings plus a delayed/third-party price feed — may be wrong or out of date, and is not a recommendation to buy or sell any security. The operator and an affiliated trading operation may hold or trade the securities EDGAR rates; see Disclosures. Past performance does not guarantee future results. Do your own research.